Not applicableStudy completedNCT06945146What this trial is testingGenomics Study in CML Patients With Ponatinib TreatmentWho this might be right forChronic Myelogenous Leukemia, BCR-ABL1 Positive Dong-Wook Kim 65
Not applicableStudy completedNCT06692803What this trial is testingReal-World Treatment Patterns and Outcomes Among Patients With Chronic Myeloid Leukemia in Earlier Lines of TherapyWho this might be right forChronic Myeloid Leukemia Novartis Pharmaceuticals 2,043
Testing effectiveness (Phase 2)Study completedNCT03625388What this trial is testingLow Dose Dasatinib (50 mg Daily) as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid LeukemiaWho this might be right forChronic Myelogenous Leukemia Hikma Pharmaceuticals LLC 56
Testing effectiveness (Phase 2)Study completedNCT02896842What this trial is testingA Prospective Randomized Phase II Study Evaluating the Monitoring of Imatinib Mesylate Plasmatic Through Level in Patients Newly Diagnosed With CP-CMLWho this might be right forLeukemia, Myelogenous, Chronic, BCR-ABL Positive Versailles Hospital 139
Testing effectiveness (Phase 2)Study completedNCT00823524What this trial is testingDonor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more Asan Medical Center 47
Large-scale testing (Phase 3)Ended earlyNCT02115386What this trial is testingTrial to Evaluate the Improvement of Chronic Low-grade AEs in Patients With Ph+ CML With Optimal Response to Imatinib When Switched to NilotinibWho this might be right forPhiladelphia Positive (Ph+) Chronic Myeloid Leukemia Novartis Pharmaceuticals 7
Large-scale testing (Phase 3)Study completedNCT00003687What this trial is testingTreatment for Chronic Pain in Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+6 more NCIC Clinical Trials Group 87
Not applicableUnknownNCT03933852What this trial is testingObservational Study on Chronic Myeloid Leukemia Patients in Any Phase Treated With Ponatinib (Iclusig®) at Any DoseWho this might be right forChronic Myeloid Leukemia, Chronic Phase University of Jena 100
Not applicableUnknownNCT01562847What this trial is testingProspective Investigation of Dynamics of ABL Mutations in Imatinib Failed CML Patients Treated With NilotinibWho this might be right forChronic Myeloid Leukemia Seoul St. Mary's Hospital 125
Testing effectiveness (Phase 2)Active Not RecruitingNCT03147612What this trial is testingLow-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic LeukemiaWho this might be right forAccelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia With BCR-ABL1+3 more M.D. Anderson Cancer Center 22
Large-scale testing (Phase 3)Study completedNCT02730299What this trial is testingStem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDSWho this might be right forHematological MalignanciesAcute Lymphoblastic Leukemia (ALL)Acute Myelogenous Leukemia (AML)+4 more Gamida Cell ltd 125
Early research (Phase 1)Study completedNCT01751919What this trial is testingA Clinical Trial to Compare the Pharmacokinetics of Imatinib Mesylate Tablet 400mg (1 Tablet) and Glivec Film-coated Tablet 100mg (4 Tablets)(Phase I)Who this might be right forChronic Myeloid LeukemiaGastrointestinal Stromal Tumor Dong-A ST Co., Ltd. 37
Not applicableUnknownNCT02883036What this trial is testingVitro Study of Tigecycline to Treat Chronic Myeloid LeukemiaWho this might be right forChronic Myeloid Leukemia Nanfang Hospital, Southern Medical University 100
Early research (Phase 1)Study completedNCT01270984What this trial is testingStudy to Evaluate the Pharmacokinetic Characteristics of Luckyvec 400mg Tablet, in Healthy SubjectsWho this might be right forChronic Myeloid LeukemiaGastrointestinal Stromal Tumors Chong Kun Dang Pharmaceutical 30
Testing effectiveness (Phase 2)Study completedNCT00134004What this trial is testingFludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 210
Early research (Phase 1)Study completedNCT02352558What this trial is testingBBI608 in Adult Patients With Advanced, Refractory Hematologic MalignanciesWho this might be right forHematologic Malignancy Sumitomo Pharma America, Inc. 15
Early research (Phase 1)Study completedNCT00025415What this trial is testingImatinib Mesylate in Treating Patients With Advanced Cancer and Liver DysfunctionWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAIDS-related Peripheral/Systemic Lymphoma+78 more National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT00010283What this trial is testingBeclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or ColonWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00571662What this trial is testingSafety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell TransplantWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+6 more University of Nebraska 76
Early research (Phase 1)Study completedNCT00258271What this trial is testingCladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous LeukemiaWho this might be right forLeukemia University of Rochester 18